CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Shares withheld for taxes Chief Medical Officer gave up 7,990 shares (to pay taxes)
- 4 Grant or award Chief Business Officer acquired 2,614 shares (grant or award)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 6,826 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 4,264 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 3,862 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 4,994 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 18,157 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 2,485 shares (to pay taxes)
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 74 · 1,467 filings